Eagle Pharmaceuticals Announces “Save the Date” for 2016 Investor Day

WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)– Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (NASDAQ:EGRX)
today announced that Scott Tarriff, President and Chief Executive
Officer, David Riggs, Chief Financial Officer, and other members of
Eagle’s senior management team will host an Investor Day in New York
City on November 11, 2016.

The event will focus on the Company’s growth initiatives, R&D pipeline
and financial outlook. It will provide additional insight on Ryanodex®
for Exertional Heat Stroke and Methamphetamine and Ecstasy Intoxication,
recent product launches and new growth opportunities.

Event: Eagle Pharmaceuticals Investor Day
Date:
November 11, 2016
Time: 8:00 a.m. ET to 11:30 a.m. ET
(registration and breakfast begin at 7:00 a.m. ET).
Location: The
Pierre 2 East 61^st Street, New York City

Institutional investors and analysts who wish to register can RSVP to
Lisa Wilson, Investor Relations for Eagle Pharmaceuticals, either via
telephone at 1-212-452-2793 or e-mail at lwilson@insitecony.com.

An audio webcast of the presentation will be available by visiting the
Investor Relations section of Eagle Pharmaceuticals web site at www.eagleus.com.
A replay of the presentation will be available for 90 days.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and
commercializing injectable products that address the shortcomings, as
identified by physicians, pharmacists and other stakeholders, of
existing commercially successful injectable products. Eagle’s strategy
is to utilize the FDA’s 505(b)(2) regulatory pathway. Additional
information is available on the company’s website at www.eagleus.com.

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160927006682/en/